Sotera Health

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Sotera Health reports solid Q4 growth, cautious outlook for 2023

Sotera Health delivered growth in Q4 2022, closed a major litigation settlement, and outlined a cautious outlook for 2023. Strategic investments in EO enhancements and pharma growth signal long-term vision, while challenges in revenue and adjusted EPS are acknowledged. Overall, the company remains optimistic about future growth prospects.

Sotera Health reports Q1 revenue decline, eyes growth opportunities

Sotera Health faced revenue and EBITDA declines in Q1 2023 but remains optimistic about future growth prospects.
The company is addressing challenges in inflation, labor, and supply chains while focusing on operational improvements.
Opportunities for revenue growth exist through Nordion volumes, facility enhancements, and regulatory compliance efforts.
Overall, Sotera Health's performance reflects a mix of challenges, strengths, and opportunities for strategic advancement.

Sotera Health releases settlement funds, faces revenue declines in Q2

Sotera Health navigated challenges in Q2 2023 with declines in revenues and adjusted EBITDA but showcased strengths in strategic planning and operational efficiency.
The company's outlook remains positive, with opportunities for growth through capacity expansions and improved volumes in the second half of the year.
Addressing challenges in revenue performance and customer inventory levels will be crucial for sustaining growth and investor confidence.
Proactive measures and transparent communication underscore Sotera Health's commitment to navigating market uncertainties and driving long-term success.

Sotera Health reports revenue growth amidst challenges and opportunities

Sotera Health (SHC) delivered a mixed performance in Q3 2023 with revenue growth, margin improvement, and operational challenges.
The company maintains a strong liquidity position and is actively managing its financial metrics to drive long-term growth.
While facing challenges from external factors, Sotera Health (SHC) has opportunities to enhance efficiency and capitalize on growth prospects.

Sotera Health (SHC) posts robust Q4 results, eyes 2024 growth

Sotera Health (SHC) delivered strong financial performance in Q4 2023 and full year.
Operational achievements and resolved litigation bolstered the company's position.
Challenges include potential impact on revenue growth from Nordion contracts.
Optimistic outlook for 2024 with a focus on customer value and safety.

Sotera Health (SHC) reports robust Q1 performance and growth outlook

Sotera Health (SHC) delivered strong Q1 2024 results, reaffirming growth outlook and showcasing financial resilience.
Management's confidence in defense against lawsuits and compliance with regulations, alongside strategic investments, underpin the company's stability and growth potential.
With a focus on operational efficiency, capacity expansions, and investor engagement, Sotera Health (SHC) is poised for sustainable growth and value creation.

Sotera Health posts robust Q2 results, eyes efficiency and growth

Sotera Health delivered strong financial results in Q2 2024, supported by revenue growth and operational improvements across key segments.
Despite challenges such as FX headwinds and macroeconomic uncertainties, the company's solid liquidity position and debt refinancing strengthen its financial foundation.
Opportunities lie in optimizing cash flow, managing capital expenditures, and leveraging new board expertise for sustained growth and value creation.

Sotera Health reports robust Q3 growth, affirms 2024 outlook

Sotera Health's Q3 2024 performance reflects strong revenue and EBITDA growth across key business segments, underlining operational efficiency and market demand.
While facing challenges in regulatory compliance and market dynamics, the company's diverse strengths in critical sectors and upcoming Investor Day signal resilience and strategic focus.
By addressing challenges, leveraging opportunities, and maintaining growth momentum, Sotera Health aims to sustain its positive performance trajectory and investor appeal in the competitive landscape.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurinia Pharmaceuticals

Many traders are attracted to low-priced stocks because they come with the allure of 2x, 3x or greater short-term gains. For fundamentalists, the challenge is finding such companies that have established businesses, products and customers.

These 2 Healthcare Stocks Have Doubled in 2023

BENSALEM, Pa.--( BUSINESS WIRE )--Law Offices of Howard G. Smith reminds investors of the upcoming March 27, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC) common stock: (a) pursuant and/or traceable to the Company's November 2020 initial public offering (“IPO”); (b) pursuant and/or traceable to the Company's March 2021 secondary public offering (“SPO”); and/or (c) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”).

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sotera Health Company (SHC)

NEW YORK , Feb. 1, 2023 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sotera Health Company ("Sotera" or the "Company") (NASDAQ: SHC) certain of the Company's current and former senior executives, members of the Company's Board of Directors, Sotera's private equity shareholders, and the underwriters of the November 20, 2020, initial public offering ("IPO") and March 18, 2021, secondary public offering ("SPO") of Sotera stock. The action is brought on behalf of all persons or entities that purchased or otherwise acquired Sotera common stock: (i) pursuant and/or traceable to the Company's IPO conducted on or around November 20, 2020; (ii) pursuant and/or traceable to the Company's SPO conducted on or around March 18, 2021; and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the "Class Period").

Bronstein, Gewirtz & Grossman, LLC Notifies Sotera Health Company (SHC) Investors of Class Action and to Actively Participate

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Sotera Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - SHC

BERWYN, Pa. , Jan. 31, 2023 /PRNewswire/ -- RM LAW, P.C.

RM LAW Announces Class Action Lawsuit Against Sotera Health Company.

LOS ANGELES--( BUSINESS WIRE )--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC) common stock: (a) pursuant and/or traceable to the Company's November 2020 initial public offering (“IPO”); (b) pursuant and/or traceable to the Company's March 2021 secondary public offering (“SPO”); and/or (c) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). Sotera investors have until March 27, 2023 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Sotera Health Company (SHC) Investors

Did you lose money on investments in Sotera Health? If so, please visit Sotera Health Company Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.

SOTERA HEALTH COMPANY (NASDAQ: SHC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Sotera Health Company (SHC)

Did you lose money on investments in Sotera Health?If so, please visit Sotera Health Company Shareholder Class Action Lawsuit or contact  Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. NEW YORK , Jan. 31, 2023 /PRNewswire/ -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Sotera Health Company ("Sotera" or the "Company") common stock: (i) pursuant and/or traceable to the Company's initial public offering conducted on or around November 20, 2020 (the "IPO"); (ii) pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings"); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the "Class Period").The lawsuit was filed in the United States District Court for the Northern District of Ohio and alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.

SOTERA HEALTH COMPANY (NASDAQ: SHC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Sotera Health Company (NASDAQ: SHC)

BENSALEM, Pa.--( BUSINESS WIRE )--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC) common stock: (a) pursuant and/or traceable to the Company's November 2020 initial public offering (“IPO”); (b) pursuant and/or traceable to the Company's March 2021 secondary public offering (“SPO”); and/or (c) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). Sotera investors have until March 27, 2023 to file a lead plaintiff motion.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Sotera Health Company (SHC) Investors

Wilmington, Delaware--(Newsfile Corp. - January 26, 2023) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Sotera Health Company (NASDAQ: SHC) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-sotera-health-company.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Sotera Health Company

NEW YORK--( BUSINESS WIRE )--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Sotera Health Co. (“Sotera” or the “Company”) (NASDAQ: SHC) in the United States District Court for the Northern District of Ohio on behalf of all persons and entities who purchased or otherwise acquired Sotera securities pursuant to the November 20, 2020 IPO; pursuant to the March 18, 2021 SPO; and/or between November 20, 2020 and September 19, 2022 both dates inclusive (the “Class Period”). Investors have until March 27, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

SOTERA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sotera Health Co. and Encourages Investors to Contact the Firm

NEW YORK , Jan. 26, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Sotera Health Company (NASDAQ: SHC): (i) pursuant and/or traceable to the Company's initial public offering ("IPO") conducted on or around November 20, 2020; (ii) pursuant and/or traceable to the Company's secondary public offering ("SPO") conducted on or around March 18, 2021; and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than March 27, 2023.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Sotera Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - SHC

LOS ANGELES--( BUSINESS WIRE )--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC) investors concerning the Company's possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Sotera Health Company (SHC) on Behalf of Investors

BENSALEM, Pa.--( BUSINESS WIRE )--Law Offices of Howard G. Smith announces an investigation on behalf of Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC) investors concerning the Company's possible violations of federal securities laws.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Sotera Health Company (SHC) on Behalf of Investors

LOS ANGELES--( BUSINESS WIRE )--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company (“Sotera” or “the Company”) (NASDAQ: SHC) for violations of the federal securities laws.

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Sotera Health Company with Losses of $100,000 to Contact the Firm

SAN DIEGO--( BUSINESS WIRE )--The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Sotera Health Company (NASDAQ: SHC) common stock: (i) pursuant to the Company's initial public offering ("IPO") conducted on November 20, 2020; (ii) pursuant to the Company's secondary public offering ("SPO") conducted on September 18, 2021; or (iii) between November 20, 2020 and September 19, 2022. Sotera provides sterilization and lab testing and advisory services to the medical device and pharmaceutical industries.

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Sotera Health Company (SHC)

NEW ORLEANS--( BUSINESS WIRE )--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 27, 2023 to file lead plaintiff applications in a securities class action lawsuit against Sotera Health Company (NasdaqGS: SHC), if they purchased or otherwise acquired the Company's shares (i) pursuant and/or traceable to the Company's November 2020 initial public offering (the “IPO”); (ii) pursuant and/or traceable to the Company's March 2021 secondary public offering (the “SPO,” and together with the IPO, the “Offerings”); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Ohio.

SOTERA HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sotera Health Company - SHC

LOS ANGELES--( BUSINESS WIRE )--The Law Offices of Frank R. Cruz announces an investigation of Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC) on behalf of investors concerning the Company's possible violations of federal securities laws.

The Law Offices of Frank R. Cruz Announces Investigation of Sotera Health Company (SHC) on Behalf of Investors

LOS ANGELES, CA / ACCESSWIRE / January 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023.

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Sotera Health Company with Losses of $100,000 to Contact the Firm

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Sotera Health Company with Losses of $100,000 to Contact the Firm

NEW YORK--( BUSINESS WIRE )--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Sotera Health Company (NASDAQ: SHC): (i) pursuant and/or traceable to the Company's initial public offering (“IPO”) conducted on or around November 20, 2020; (ii) pursuant and/or traceable to the Company's secondary public offering (“SPO”) conducted on or around March 18, 2021; and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than March 27, 2023.

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sotera Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – SHC

The industry is huge and has attractive unit economics. Sotera Health has comprehensive offerings and a global scale to meet demand.

Sotera Health: Stable Long-Term Growth

The company settled a potentially devastating set of legal cases, and analysts reacted with upgrades.

Why Sotera Health Stock Rocketed a Whopping 115% This Week

Sotera Health Company (NASDAQ: SHC) is a leading global provider of mission-critical sterilization solutions, lab testing, and advisory services.

Here's Why Sotera Health Company Stock Just Doubled in a Day

The company agreed to pay $408 million in a crucial legal settlement.

News for Sotera Health Stock (SHC)